Obesity at baseline | Obesity at follow up | Overall, n | Case, n (%) | OR (95% CI) |
---|
Model 1 | Model 2 | Model 3 |
---|
General obesity†|
 No(a) | No | 2451 | 215 (8.77) | 1.00 | 1.00 | 1.00 |
 No(b) | Yes | 95 | 18 (18.95) | 3.17 (1.83–5.49) | 3.05 (1.76–5.31) | 3.04 (1.66–5.59) |
 Yes(c) | No | 85 | 8 (9.41) | 1.23 (0.58–2.62) | 1.04 (0.49–2.23) | 0.72 (0.32–1.63) |
 Yes(d) | Yes | 264 | 52 (19.70) | 3.05 (2.16–4.32) | 2.51 (1.75–3.62) | 2.22 (1.49–3.31) |
Abdominal obesity††|
 No(a) | No | 1346 | 94 (6.98) | 1.00 | 1.00 | 1.00 |
 No(b) | Yes | 319 | 33 (10.34) | 1.83 (1.20–2.81) | 1.75 (1.14–2.69) | 1.88 (1.18–2.98) |
 Yes(c) | No | 191 | 10 (5.24) | 0.82 (0.42–1.61) | 0.75 (0.38–1.49) | 0.60 (0.29–1.23) |
 Yes(d) | Yes | 1039 | 156 (15.01) | 2.87 (2.15–3.83) | 2.48 (1.83–3.35) | 2.14 (1.54–2.97) |
- Model 1: Adjusted for age, gender, residence, marriage, education, smoking history, and drinking status
- Model 2: Adjusted for all variables in Model 1 plus hypertension, dyslipidemia, diabetes mellitus, stroke, and depression
- Model 3: Adjusted for all variables in Model 2 plus fasting plasma glucose, glycated hemoglobin, total cholesterol, C-reactive protein, blood urea nitrogen, creatinine, and baseline SUA
- BMI body mass index, CI confidence interval, OR odds ratio, SUA serum uric acid
- Change in obesity status is defined as (a) no obesity, (b) incident obesity, (c) remittent obesity, and (d) persistent obesity
- †General obesity is determined using BMI; ††Abdominal obesity is determined using waist circumference
- Values in italics are statistically significant (P < 0.05)